Altre lingue Pyxis Oncology, Inc.

Azioni

PYXS

US7473241013

Mercato chiuso - Nasdaq Altri mercati azionari 22:00:00 02/07/2024			Variaz. 5gg	Var. 1 gen.
2,94 ^USD	-8,12%		-3,92%	+63,33%

10/06	Pyxis Oncology, Inc. nomina Michael A. Metzger nel suo Consiglio di Amministrazione	CI
14/05	Pyxis Oncology, Inc. riporta i risultati degli utili per il primo trimestre conclusosi il 31 marzo 2024	CI

Altre lingue

Sblocca tutte le notizie: sii il primo a essere informato e reagisci prima dei mercati!

Registrazione 100% gratuita

Pyxis Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)	28/06
Pyxis Oncology, Inc. Appoints Michael A. Metzger to Its Board of Directors	10/06
Pyxis Oncology Expands Board of Directors with Appointment of Michael A. Metzger	10/06
Pyxis Oncology to Participate in a Fireside Chat at the Jefferies Global Healthcare Conference	30/05
Pyxis Oncology : RBC Capital Markets Global Healthcare Conference	15/05
Pyxis Oncology, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	14/05
Earnings Flash (PYXS) PYXIS ONCOLOGY Posts Q1 Revenue $16.1M	14/05
Pyxis Oncology Provides Corporate Update and Reports Financial Results for First Quarter 2024	14/05
Pyxis Oncology Provides Corporate Update and Reports Financial Results for First Quarter 2024	14/05
Pyxis Oncology, Inc. Appoints Stephen Worsley as its Senior Vice President	14/05
Pyxis Oncology to Present at the RBC Capital Markets Global Healthcare Conference	09/05
Pyxis Oncology to Present at the RBC Capital Markets Global Healthcare Conference	09/05
Pyxis Oncology : Stifel 2024 Virtual Targeted Oncology Forum	17/04
Pyxis Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)	28/03
Pyxis Oncology Obtains $8 Million Payment for the Sale of Royalty Rights	27/03
Health Care Up on Drug Sales Optimism -- Health Care Roundup	21/03
Pyxis Oncology Provides Corporate Update and Reports Financial Results for Fourth Quarter and Full Year 2023	21/03
Pyxis Oncology, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	21/03
Pyxis Oncology Expands Board of Directors with Appointment of Santhosh Palani, Ph.D., CFA	13/03
Pyxis Oncology Expands Board of Directors with Appointment of Santhosh Palani, Ph.D., CFA	13/03

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue Pyxis Oncology, Inc.

Azioni

PYXS

US7473241013

Altre lingue

Filtri